TY - JOUR AU - Saito, Motonobu AU - Kono, Koji AU - Kohno, Takashi PY - 2018 TI - Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1 Y2 - 2018 KW - N2 - Molecular targeted therapy against driver gene aberrations has a significantly high positive response rate compared with traditional cytotoxic chemotherapies, and has thus dramatically changed the treatment strategies for malignant tumors, including non-small cell lung cancer (NSCLC) (1). Lung adenocarcinoma (LADC) can be treated with targeted therapy against driver gene aberrations using tyrosine kinase inhibitors (TKIs). UR - https://tlcr.amegroups.org/article/view/23560